Studying monkeypox infection and vaccine in adults
Treatments studied
Part of Infections clinical trials.
This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older).
- You either may need the monkeypox (MPXV) vaccine based on French health guidance, or you may have suspected monkeypox infection.
- You must be able to give about one small blood draw totaling 45 ml in a single visit.
- You must be able to give informed consent (understand the study and agree).
- You must have French Social Health Insurance coverage.
- If you are getting the vaccine, you can’t have any vaccine reason you should not receive it (other than a current infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how well antibodies from COVID-19 or monkeypox vaccines or treatments work in adults. It helps researchers understand your protection level.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study examines how your body's immune system remembers and responds to monkeypox infection. Researchers will analyze blood samples to understand the types of immunity you develop, which may help improve future treatments and vaccines.
This is an observational study that follows adults after they get a monkeypox vaccine to learn how their immune system responds. The results may help researchers understand what types of protection the vaccine creates.
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
Hear when a new Monkey Pox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.